NanoLC‐FT‐ICR MS improves proteome coverage attainable for ∼3000 laser‐microdissected breast carcinoma cells
Authors:
- 5 January 2007
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 7 (2) , 323-329
Abstract
Proteomics assays hold great promise for unraveling molecular events that underlie human diseases. Effective analysis of clinical samples is essential, but this task is considerably complicated by tissue heterogeneity. Laser capture microdissection (LCM) can be used to selectively isolate target cells from their native tissue environment. However, the small number of cells that is typically procured by LCM severely limits proteome coverage and biomarker discovery potential achievable by conventional proteomics platforms. Herein, we describe the use of nanoLC‐FT‐ICR MS for analyzing protein digests of ˜3000 LCM‐derived tumor cells from breast carcinoma tissue, corresponding to ˜300 ng of total protein. A total of 2282 peptides were identified by matching LC‐MS data to accurate mass and time (AMT) tag databases that were previously established for human breast (cancer) cell lines. One thousand and three unique proteins were confidently identified with two or more peptides. Based on gene ontology categorization, identified proteins appear to cover a wide variety of biological functions and cellular compartments. This work demonstrates that a substantial number of proteins can be detected and identified from limited number of cells using the AMT tag approach, and opens doors for high‐throughput in‐depth proteomics analysis of clinical samples.Keywords
This publication has 32 references indexed in Scilit:
- Robust Algorithm for Alignment of Liquid Chromatography−Mass Spectrometry Analyses in an Accurate Mass and Time Tag Data Analysis PipelineAnalytical Chemistry, 2006
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Advances in proteomics data analysis and display using an accurate mass and time tag approachMass Spectrometry Reviews, 2006
- Comparison of Normal and Breast Cancer Cell Lines Using Proteome, Genome, and Interactome DataJournal of Proteome Research, 2005
- Proteome Analysis of Microdissected Tumor Tissue Using a Capillary Isoelectric Focusing-Based Multidimensional Separation Platform Coupled with ESI-Tandem MSAnalytical Chemistry, 2005
- Method optimisation for peptide profiling of microdissected breast carcinoma tissue by matrix‐assisted laser desorption/ionisation‐time of flight and matrix‐assisted laser desorption/ionisation‐time of flight/time of flight‐mass spectrometryProteomics, 2005
- High-Throughput Comparative Proteome Analysis Using a Quantitative Cysteinyl-peptide Enrichment TechnologyAnalytical Chemistry, 2004
- An approach to the proteomic analysis of a breast cancer cell line (SKBR‐3)Proteomics, 2003
- Stage at diagnosis is a key explanation of differences in breast cancer survival across EuropeInternational Journal of Cancer, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002